Lars Fjellbirkeland

Associate Professor - Department of Respiratory Medicine

Norwegian version of this page

Email lars.fjellbirkeland@medisin.uio.no

Mobile phone +47 94055618

Username

Visiting address Sognsvannsveien 20 Rikshospitalet 0372 Oslo

Postal address Postboks 4950 Nydalen OUS HF Rikshospitalet 0424 Oslo

Download business card

Lærum, Dan; Strand, Trond-Eirik; Brustugun, Odd Terje; Gallefoss, Frode; Falk, Ragnhild Sørum & Durheim, Michael Thomas [Show all 7 contributors for this article] (2024). Evaluation of sex inequity in lung-cancer-specific survival. Acta Oncologica. ISSN 0284-186X. 63, p. 343–350. doi: 10.2340/1651-226X.2024.27572.
Nilssen, Yngvar; Brustugun, Odd Terje; Fjellbirkeland, Lars; Grønberg, Bjørn Henning; Haram, Per Magnus & Helbekkmo, Nina [Show all 10 contributors for this article] (2024). Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends. Clinical Lung Cancer. ISSN 1525-7304. doi: 10.1016/j.cllc.2024.04.002.
Nilssen, Yngvar; Brustugun, Odd Terje; Fjellbirkeland, Lars; Helland, Åslaug; Møller, Bjørn & Wahl, Sissel Gyrid Freim [Show all 7 contributors for this article] (2024). Distribution and characteristics of malignant tumours by lung lobe. BMC Pulmonary Medicine. ISSN 1471-2466. 24(1). doi: 10.1186/s12890-024-02918-w.
Rakaee, Mehrdad; Andersen, Sigve; Giannikou, K.; Paulsen, Erna-Elise; Kilvær, Thomas Karsten & Busund, Lill-Tove Rasmussen [Show all 25 contributors for this article] (2023). Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial. Annals of Oncology. ISSN 0923-7534. doi: 10.1016/j.annonc.2023.04.005. Full text in Research Archive
Gouliaev, A.; Rasmussen, T.R.; Malila, N.; Fjellbirkeland, Lars; Löfling, Lukas & Jakobsen, E. [Show all 8 contributors for this article] (2023). Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization. Acta Oncologica. ISSN 0284-186X. 62(1), p. 1–7. doi: 10.1080/0284186X.2023.2172687.
Solberg, Steinar; Nilssen, Yngvar; Brustugun, Odd Terje; Haram, Per Magnus; Helland, Åslaug & Møller, Bjørn [Show all 9 contributors for this article] (2022). Concordance between clinical and pathology TNM-staging in lung cancer. Lung Cancer. ISSN 0169-5002. 171, p. 65–69. doi: 10.1016/j.lungcan.2022.07.014. Full text in Research Archive
Lærum, Dan; Brustugun, Odd Terje; Gallefoss, Frode; Falk, Ragnhild Sørum; Strand, Trond-Eirik & Fjellbirkeland, Lars (2021). Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer. Cancer Treatment and Research Communications. ISSN 2468-2942. 29. doi: 10.1016/j.ctarc.2021.100477. Full text in Research Archive
Lærum, Dan; Brustugun, Odd Terje; Gallefoss, Frode; Falk, Ragnhild Sørum; Strand, Trond-Eirik & Fjellbirkeland, Lars (2020). Reduced delays in diagnostic pathways for non-small cell lung cancer after local and National initiatives. Cancer Treatment and Research Communications. ISSN 2468-2942. 23. doi: 10.1016/j.ctarc.2020.100168. Full text in Research Archive
Thøgersen, Håvard; Møller, Bjørn; Åsli, Linn Merete; Bhargava, Sameer; Kvåle, Rune & Fjellbirkeland, Lars [Show all 10 contributors for this article] (2020). Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population. Acta Oncologica. ISSN 0284-186X. 59(4), p. 376–383. doi: 10.1080/0284186X.2019.1711167. Full text in Research Archive
Solberg, Steinar; Nilssen, Yngvar; Brustugun, Odd Terje; Grimsrud, Tom Kristian; Haram, Per Magnus & Helbekkmo, Nina [Show all 15 contributors for this article] (2019). Increase in curative treatment and survival of lung cancer in Norway 2001-2016. European Journal of Epidemiology (EJE). ISSN 0393-2990. 34(10), p. 951–955. doi: 10.1007/s10654-019-00536-z. Full text in Research Archive
Brustugun, Odd Terje; Grønberg, Bjørn Henning; Fjellbirkeland, Lars; Helbekkmo, Nina; Aanerud, Marianne & Grimsrud, Tom Kristian [Show all 11 contributors for this article] (2018). Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer. ISSN 0169-5002. 122, p. 138–145. doi: 10.1016/j.lungcan.2018.06.003. Full text in Research Archive
Nilssen, Yngvar; Strand, Trond-Eirik; Fjellbirkeland, Lars; Bartnes, Kristian; Brustugun, Odd Terje & O'Connell, Dianne L [Show all 8 contributors for this article] (2016). Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage. International Journal of Cancer. ISSN 0020-7136. 138(6), p. 1350–1360. doi: 10.1002/ijc.29875.
Nilssen, Yngvar; Strand, Trond-Eirik; Fjellbirkeland, Lars; Bartnes, Kristian & Møller, Bjørn (2016). Lung cancer survival in Norway, 1997-2011: From nihilism to optimism. European Respiratory Journal. ISSN 0903-1936. 47(1), p. 275–287. doi: 10.1183/13993003.00650-2015.
Berg, Janna; Fjellbirkeland, Lars; Suhrke, Pål; Jebsen, Peter Wilhelm; Lund-Iversen, Marius & Kleinberg, Lilach [Show all 9 contributors for this article] (2016). EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust. Acta Oncologica. ISSN 0284-186X. 55(2), p. 149–155. doi: 10.3109/0284186X.2015.1062537.
Brustugun, Odd Terje; Helland, Åslaug; Fjellbirkeland, Lars; Kleinberg, Lilach; Ariansen, Sarah Louise & Jebsen, Peter Wilhelm [Show all 15 contributors for this article] (2012). Mutasjonstesting ved ikke-småcellet lungekreft. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 132(8), p. 952–955. doi: 10.4045/tidsskr.11.1017. Full text in Research Archive
Lund-Iversen, Marius; Kleinberg, Lilach; Fjellbirkeland, Lars; Helland, Åslaug & Brustugun, Odd Terje (2012). Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations. Journal of Thoracic Oncology. ISSN 1556-0864. 7(9), p. 1471–1473. doi: 10.1097/JTO.0b013e3182614a9d.
Fjellbirkeland, Lars; Laerum, Ole Didrik; Eide, Geir Egil & Bjerkvig, Rolf (1998). Invasiveness by lacZ transfected non-small cell lung cancer cells into human bronchial tissues in vitro. Lung Cancer. ISSN 0169-5002. 21(1), p. 7–19.

View all works in Cristin

Brustugun, Odd Terje; Sørhaug, Sveinung; Grønberg, Bjørn Henning; Aanerud, Marianne; Al-Zubaydi, Mohammed Modar & Fjellbirkeland, Lars [Show all 13 contributors for this article] (2020). Lungekreft: Forbedret prognose gir kapasitetsutfordringer. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 140(5). doi: 10.4045/tidsskr.20.0014.
Amundsen, Tore; Fløtten, Øystein; Bugge, Anders Standal; Fjellbirkeland, Lars; Richardsen, Elin & Nesgård, Kristin [Show all 8 contributors for this article] (2013). Nasjonal handlingsplan for lungekreft (for Helsedirektoratet, HD og Norwegian Lung Cancer Group, NLCG) - utredning og behandling (utredningskapittelet). Show summary
Nasjonal handlingsplan for lungekreft - utredning og behandling (utredningskapittelet) utført av Norsk Lunge Cancer Gruppe (NLCG) på oppfordring av Helsedirektoratet

View all works in Cristin

Published Apr. 13, 2011 2:54 PM - Last modified May 27, 2011 4:07 PM